Literature DB >> 22101366

The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain.

Tsuyoshi Hamaguchi1, Yvonne S Eisele, Nicholas H Varvel, Bruce T Lamb, Lary C Walker, Mathias Jucker.   

Abstract

The deposition of the β-amyloid (Aβ) peptide in senile plaques and cerebral Aβ-amyloid angiopathy can be seeded in β-amyloid precursor protein (APP)-transgenic mice by the intracerebral infusion of brain extracts containing aggregated Aβ. Previous studies of seeded β-amyloid induction have used relatively short incubation periods to dissociate seeded β-amyloid induction from endogenous β-amyloid deposition of the host, thus precluding the analysis of the impact of age and extended incubation periods on the instigation and spread of Aβ lesions in brain. In the present study using R1.40 APP-transgenic mice (which do not develop endogenous Aβ deposition up to 15 months of age) we show that: (1) seeding at 9 months of age does not induce more Aβ deposition than seeding at 3 months of age, provided that the incubation period (6 months) is the same; and (2) very long-term (12 months) incubation after a focal application of the seed results in the emergence of Aβ deposits throughout the forebrain. These findings indicate that the presence of Aβ seeds, and not the age of the host per se, is critical to the initiation of Aβ aggregation in the brain, and that Aβ deposition, actuated in one brain area, eventually spreads throughout the brain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101366      PMCID: PMC3297471          DOI: 10.1007/s00401-011-0912-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  30 in total

1.  Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.

Authors:  M D Kane; W J Lipinski; M J Callahan; F Bian; R A Durham; R D Schwarz; A E Roher; L C Walker
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

2.  Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.

Authors:  L S Kulnane; B T Lamb
Journal:  Neurobiol Dis       Date:  2001-12       Impact factor: 5.996

3.  Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease.

Authors:  Joel C Watts; Kurt Giles; Sunny K Grillo; Azucena Lemus; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

Review 4.  Ageing and protein aggregation-mediated disorders: from invertebrates to mammals.

Authors:  Andrew Dillin; Ehud Cohen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-12       Impact factor: 6.237

5.  Resolving controversies on the path to Alzheimer's therapeutics.

Authors:  Dennis J Selkoe
Journal:  Nat Med       Date:  2011-09-07       Impact factor: 53.440

6.  Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.

Authors:  Yvonne S Eisele; Ulrike Obermüller; Götz Heilbronner; Frank Baumann; Stephan A Kaeser; Hartwig Wolburg; Lary C Walker; Matthias Staufenbiel; Mathias Heikenwalder; Mathias Jucker
Journal:  Science       Date:  2010-10-21       Impact factor: 47.728

Review 7.  Epidemiology of Alzheimer disease.

Authors:  Christiane Reitz; Carol Brayne; Richard Mayeux
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

Review 8.  Biological and chemical approaches to diseases of proteostasis deficiency.

Authors:  Evan T Powers; Richard I Morimoto; Andrew Dillin; Jeffery W Kelly; William E Balch
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation.

Authors:  Yvonne S Eisele; Tristan Bolmont; Mathias Heikenwalder; Franziska Langer; Laura H Jacobson; Zheng-Xin Yan; Klaus Roth; Adriano Aguzzi; Matthias Staufenbiel; Lary C Walker; Mathias Jucker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

10.  Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

Authors:  T Kawarabayashi; L H Younkin; T C Saido; M Shoji; K H Ashe; S G Younkin
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

View more
  44 in total

1.  Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.

Authors:  Zane Jaunmuktane; Simon Mead; Matthew Ellis; Jonathan D F Wadsworth; Andrew J Nicoll; Joanna Kenny; Francesca Launchbury; Jacqueline Linehan; Angela Richard-Loendt; A Sarah Walker; Peter Rudge; John Collinge; Sebastian Brandner
Journal:  Nature       Date:  2015-09-10       Impact factor: 49.962

Review 2.  Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nature       Date:  2013-09-05       Impact factor: 49.962

Review 3.  β-Amyloid Prions and the Pathobiology of Alzheimer's Disease.

Authors:  Joel C Watts; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 4.  Neurodegenerative diseases: expanding the prion concept.

Authors:  Lary C Walker; Mathias Jucker
Journal:  Annu Rev Neurosci       Date:  2015-03-30       Impact factor: 12.449

5.  Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone.

Authors:  David J Irwin; Joseph Y Abrams; Lawrence B Schonberger; Ellen Werber Leschek; James L Mills; Virginia M-Y Lee; John Q Trojanowski
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

Review 6.  Corruption and spread of pathogenic proteins in neurodegenerative diseases.

Authors:  Lary C Walker; Harry LeVine
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

7.  Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Ghulam M Ashraf; Nigel H Greig; Taqi A Khan; Iftekhar Hassan; Shams Tabrez; Shazi Shakil; Ishfaq A Sheikh; Syed K Zaidi; Mohammad Akram; Nasimudeen R Jabir; Chelaprom K Firoz; Aabgeena Naeem; Ibrahim M Alhazza; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

Review 8.  The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.

Authors:  Lary C Walker; Juliane Schelle; Mathias Jucker
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

Review 9.  Mouse models for studying the formation and propagation of prions.

Authors:  Joel C Watts; Stanley B Prusiner
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

10.  Cyclooxygenase-2 is critical for the propagation of β-amyloid protein and reducing the glycosylation of tau in Alzheimer's disease.

Authors:  Pei-Pei Guan; Xin Yu; Yan-Hui Zou; Pu Wang
Journal:  Cell Mol Immunol       Date:  2019-09-24       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.